8-K
SRX Global Inc. Enters Into Stock Purchase Agreement to Acquire CERo Therapeutics, Inc.
8-K
SRX Global Commits $1.5 Million to Launch Family of AI-Powered ETFs through EMJX Platform
8-K
SRX Global Inc. Enters into Limited Consent and Amendment Agreement for Stock Repurchase Plan
8-K
SRX Global Inc. Enters into Secured Financing Transaction with CERo Therapeutics Holdings, Inc.
8-K
SRX Global Inc. Announces Private Placement of Series C Convertible Preferred Stock
8-K
SRX Global Inc. Reports Fiscal Third Quarter 2026 Financial Results and Strategic Updates